“Dexamethasing” acute myeloid leukemia: new opportunities for an “old” drug

Authors

Jesús Duque‐Afonso (ORCID: https://orcid.org/0000-0002-8287-5673)
Michael Lübbert (ORCID: https://orcid.org/0000-0003-1186-1650)
Julian List

Institutions

University Medical Center Freiburg (DE)

Publication Details

Journal: Haematologica
Published: 2025-05-29
DOI: https://doi.org/10.3324/haematol.2025.287404
Primary Topic: Acute Myeloid Leukemia Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

“Dexamethasing” acute myeloid leukemia: new opportunities for an “old” drug

Jesús Duque‐Afonso, Michael Lübbert, Julian List

May 29, 2025

Haematologica

Acute Myeloid Leukemia Research

article

“Dexamethasing” acute myeloid leukemia: new opportunities for an “old” drug

Jesús Duque‐Afonso, Michael Lübbert, Julian List

May 29, 2025article en

Abstract

No abstract available for this paper.

HaematologicaVol. 110(10)

University Medical Center Freiburg (DE)

Openalex Percentile: Top 85%

Acute Myeloid Leukemia Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

“Dexamethasing” acute myeloid leukemia: new opportunities for an “old” drug — Jesús Duque‐Afonso, Michael Lübbert, et al. · Haematologica (2025) | TGRS Research Map | TGRS